Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation

• Publication date

  2015-05-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.114.013220PMID 25995320PMCID PMC4479965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-22 Regulates Cardiac Hypertrophy and Remodeling in Response to Stress

  2013cited by this paper
• Circulating microRNAs have a sex-specific association with metabolic syndrome

  2013cited by this paper
• MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors

  2013cited by this paper
• Resolution of left bundle branch block-induced cardiomyopathy by cardiac resynchronization therapy.

  2013cited by this paper
• QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy.

  2013cited by this paper
• Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration.

  2012cited by this paper
• Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs

  2012cited by this paper
• Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.

  2012cited by this paper
• Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

  2012cited by this paper
• Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.

  2012cited by this paper
• MicroRNAs in vascular and metabolic disease.

  2012cited by this paper
• Pathological Role of Serum- and Glucocorticoid-Regulated Kinase 1 in Adverse Ventricular Remodeling

  2012cited by this paper
• Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF (Cardiac Resynchronization in Heart Failure) trial

  2012cited by this paper
• Cardiomyocyte Microvesicles Contain DNA/RNA and Convey Biological Messages to Target Cells

  2012cited by this paper
• Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure

  2011cited by this paper
• Clinical ResearchCardiac Resynchronization TherapyReduction of the Risk of Recurring Heart Failure Events With Cardiac Resynchronization Therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

  2011cited by this paper
• Extracellular/circulating microRNAs and their potential role in cardiovascular disease.

  2011cited by this paper
• TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support

  2011cited by this paper
• Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.

  2011cited by this paper
• inSilicoDb: an R/Bioconductor package for accessing human Affymetrix expert-curated datasets from GEO

  2011cited by this paper
• MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts

  2010cited by this paper
• Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription.

  2009cited by this paper
• Reversal of Global Apoptosis and Regional Stress Kinase Activation by Cardiac Resynchronization

  2008cited by this paper
• An epidemic of dyssynchrony: but what does it mean?

  2008cited by this paper
• Abstract 5340: Cardiac Resynchronization Therapy Corrects Dyssynchrony-induced Regional Gene Expression Changes on a Genomic Level

  2008cited by this paper
• Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.

  2008cited by this paper
• The database of experimentally supported targets: a functional update of TarBase

  2008cited by this paper
• Usefulness of a novel "response score" to predict hemodynamic and clinical outcome from cardiac resynchronization therapy.

  2006cited by this paper
• Akt1 Is Required for Physiological Cardiac Growth

  2006cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• The microRNA Registry

  2004cited by this paper
• limmaGUI: A graphical user interface for linear modeling of microarray data

  2004cited by this paper
• Ventricular resynchronization: pathophysiology and identification of responders.

  2003cited by this paper
• Regional Alterations in Protein Expression in the Dyssynchronous Failing Heart

  2003influential reference
• Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart*

  2002cited by this paper
• Pulsatile Stretch Remodels Cell-to-Cell Communication in Cultured Myocytes

  2000cited by this paper
• Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism.

  1993influential reference
• More powerful procedures for multiple significance testing.

  1990cited by this paper

• miRNAs in Pulmonary Hypertension: Mechanistic Insights and Therapeutic Potential

  2025cites this paper
• Remodeling of non-coding RNA regulatory networks: Decoding the pathological mechanisms and new therapeutic paradigms of cardiovascular diseases.

  2025cites this paper
• The Role of MicroRNAs in the Pathophysiology and Management of Heart Failure: From Molecular Mechanisms to Clinical Application

  2025cites this paper
• miR-30d Levels Predict Re-Hospitalization in Patients with Acute Cardiogenic Pulmonary Edema: A Preliminary Study

  2025cites this paper
• From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure

  2025cites this paper
• The Heart’s Small Molecules: The Importance of MicroRNAs in Cardiovascular Health

  2025cites this paper
• Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease

  2024cites this paper
• Decoding the secrets of longevity: unraveling nutraceutical and miRNA-Mediated aging pathways and therapeutic strategies

  2024cites this paper
• Myocardial delivery of miR30d with peptide-functionalized milk-derived extracellular vesicles for targeted treatment of hypertrophic heart failure.

  2024cites this paper
• Exosome-mediated secretion of miR-127-3p regulated by RAB27A accelerates metastasis in renal cell carcinoma

  2024cites this paper
• Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes

  2024cites this paper
• Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches.

  2024cites this paper
• MicroRNAs and Cardiovascular Disease Risk

  2024cites this paper
• CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology

  2024cites this paper
• A perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision research

  2024cites this paper
• MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure

  2024cites this paper
• miR‐30d Attenuates Pulmonary Arterial Hypertension via Targeting MTDH and PDE5A and Modulates the Beneficial Effect of Sildenafil

  2024cites this paper
• Exercise Training-Induced MicroRNA Alterations with Protective Effects in Cardiovascular Diseases

  2023cites this paper
• New insights into the cardio-renal benefits of SGLT2 inhibitors and the coordinated role of miR-30 family

  2023influential citation
• Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential

  2023cites this paper
• Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy?

  2023cites this paper
• Non-Coding RNAs in Cell-to-Cell Communication: Exploiting Physiological Mechanisms as Therapeutic Targets in Cardiovascular Pathologies

  2023cites this paper
• MiRNA-30d and miR-770-5p as potential clinical risk predictors of Vasoplegic Syndrome in Patients undergoing on-pump coronary artery bypass grafting

  2023cites this paper
• Impact of extracellular vesicles on the pathogenesis, diagnosis, and potential therapy in cardiopulmonary disease

  2023cites this paper
• Apoptosis and heart failure: The role of non-coding RNAs and exosomal non-coding RNAs.

  2023cites this paper
• Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets

  2023cites this paper
• MicroRNA‐30d and ‐483‐3p for bi‐ventricular remodelling and miR‐126‐3p for pulmonary hypertension in advanced heart failure

  2023cites this paper
• Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy.

  2023cites this paper
• MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction

  2023cites this paper
• The Regulation of Pyroptosis and Ferroptosis by MicroRNAs in Cardiovascular Diseases

  2023cites this paper
• The microRNA Expression Profiling in Heart Failure: A Systematic Review and Meta-Analysis

  2022cites this paper
• New Biomarkers and Their Potential Role in Heart Failure Treatment Optimisation—An African Perspective

  2022cites this paper
• Biomarkers in HFpEF for Diagnosis, Prognosis, and Biological Phenotyping

  2022cites this paper
• Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1

  2022cites this paper
• Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats

  2022cites this paper
• Targeting miR-30d reverses pathological cardiac hypertrophy

  2022cites this paper
• Epigenetics in precision medicine of cardiovascular disease

  2022cites this paper
• Epigenetics in Precision Nutrition

  2022cites this paper
• AMD Genomics: Non-Coding RNAs as Biomarkers and Therapeutic Targets

  2022cites this paper
• Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies

  2022cites this paper
• Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy

  2022cites this paper
• CARD9 Regulation and its Role in Cardiovascular Diseases

  2022cites this paper
• 17-estradiol nanoparticles influence inflammatory response of myocardial infarction possibly through downregulation of miR-302b.

  2021cites this paper
• Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue

  2021cites this paper
• Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach

  2021cites this paper
• miR‐10396b‐3p inhibits mechanical stress‐induced ligamentum flavum hypertrophy by targeting IL‐11

  2021cites this paper
• Value of miR-30d and miR-146a as Prognostic Biomarkers for Heart Failure Development Post Myocardial Infarction

  2021cites this paper
• MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease

  2021cites this paper
• Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.

  2021cites this paper
• AhR/miR-23a-3p/PKCα axis contributes to memory deficits in ovariectomized and normal aging female mice

  2021cites this paper
• SnRNA sequencing defines signaling by RBC-derived extracellular vesicles in the murine heart

  2021cites this paper
• Potential clinical applications of exosomes in the diagnosis, treatment, and prognosis of cardiovascular diseases: a narrative review

  2021cites this paper
• Impact of Cardiac Resynchronization Therapy on Global and Cardiac Metabolism and Cardiac Mitochondrial Function.

  2021cites this paper
• Up‐regulation of microRNA‐30b/30d cluster represses hepatocyte apoptosis in mice with fulminant hepatic failure by inhibiting CEACAM1

  2020cites this paper
• MicroRNA and Cardiovascular Diseases

  2020cites this paper
• Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association

  2020cites this paper
• Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?

  2020cites this paper
• A Case for Adaptive Cardiac Hypertrophic Remodeling Is CITED.

  2020cites this paper
• Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease.

  2020cites this paper
• Non-coding RNAs - Update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.

  2020cites this paper
• Mir-30d Regulates Cardiac Remodeling by Intracellular And Paracrine Signaling.

  2020cites this paper
• MicroRNA‐26a Protects the Heart Against Hypertension‐Induced Myocardial Fibrosis

  2020cites this paper
• Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs

  2020cites this paper
• The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure

  2020cites this paper
• CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress

  2020cites this paper
• MicroRNAs in Cardiovascular Disease.

  2020cites this paper
• Red blood cell-derived extracellular vesicles mediate intercellular communication in ischemic heart failure

  2019cites this paper
• Biomarkers to predict the response to cardiac resynchronization therapy.

  2019cites this paper
• Circulating extracellular RNAs, myocardial remodeling, and heart failure in patients with acute coronary syndrome

  2019cites this paper
• Usefulness of Biomarkers for Predicting Response to Cardiac Resynchronization Therapy

  2019cites this paper
• Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles

  2019cites this paper
• Identification of atrial fibrillation-associated microRNAs in left and right atria of rheumatic mitral valve disease patients.

  2019cites this paper
• Circulating Long Non-coding RNA ENST00000507296 Is a Prognostic Indicator in Patients with Dilated Cardiomyopathy

  2019cites this paper
• Identification of FBXW7α-regulated genes in M1-polarized macrophages in colorectal cancer by RNA sequencing

  2019cites this paper
• The value of serum metabolomics analysis in predicting the response to cardiac resynchronization therapy

  2019cites this paper
• Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.

  2019cites this paper
• miRNAs in drug response variability: potential utility as biomarkers for personalized medicine.

  2019cites this paper
• Circulating MicroRNAs: New Avenues for Heart Failure Classification?

  2019cites this paper
• The mechanical effects of CRT promoting autophagy via mitochondrial calcium uniporter down‐regulation and mitochondrial dynamics alteration

  2019cites this paper
• The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research.

  2019cites this paper
• Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation.

  2019cites this paper
• Upregulation of miR-29b-3p protects cardiomyocytes from hypoxia-induced apoptosis by targeting TRAF5

  2019cites this paper
• Engagement of circular RNA HECW2 in the nonautophagic role of ATG5 implicated in the endothelial-mesenchymal transition

  2018cites this paper
• MicroRNAs Associated With Reverse Left Ventricular Remodeling in Humans Identify Pathways of Heart Failure Progression

  2018cites this paper
• miR-21 suppression prevents cardiac alterations induced by d-galactose and doxorubicin.

  2018cites this paper
• Expression profile of microRNAs in expressed prostatic secretion of healthy men and patients with IIIA chronic prostatitis/chronic pelvic pain syndrome

  2018cites this paper
• Advances, challenges, and opportunities in extracellular RNA biology: insights from the NIH exRNA Strategic Workshop.

  2018cites this paper
• Dysregulation of valvular interstitial cell let-7c, miR-17, miR-20a, and miR-30d in naturally occurring canine myxomatous mitral valve disease

  2018cites this paper
• Extracellular RNA Isolation from Cell Culture Supernatant.

  2018cites this paper
• Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?

  2018cites this paper
• Extracellular RNAs: A New Awareness of Old Perspectives.

  2018cites this paper
• Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction

  2018influential citation
• Extracellular RNA profiles with human age

  2018cites this paper
• Molecular Regulatory Pathways Link Sepsis With Metabolic Syndrome: Non-coding RNA Elements Underlying the Sepsis/Metabolic Cross-Talk

  2018cites this paper
• miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges

  2018cites this paper
• Relationship between cardiovascular diseases and circulating cell-free nucleic acids in human plasma.

  2018cites this paper
• Inhalation of Hydrogen Attenuates Progression of Chronic Heart Failure via Suppression of Oxidative Stress and P53 Related to Apoptosis Pathway in Rats

  2018cites this paper
• Cardiac contractility modulation improves left ventricular systolic function partially via miR-25 mediated SERCA2A expression in rabbit trans aortic constriction heart failure model.

  2018cites this paper
• Combination of peripheral blood mononuclear cell miR-19b-5p, miR-221, miR-25-5p, and hypertension correlates with an increased heart failure risk in coronary heart disease patients

  2018cites this paper
• Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases

  2018cites this paper